Biotinylated Human LRRC15 / LIB Protein, Fc,Avitag™ (MALS verified)
Product specifications
Biotinylated Human LRRC15 Protein, Fc,Avitag (LR5-H82F9) is expressed from human 293 cells (HEK293). It contains AA Tyr 22 – Gly 538 (Accession # Q8TF66-1).
This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 86.1 kDa. The protein migrates as 95-110 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Catalog Number
LR5-H82F9-25ug
Product Category
Proteins & Peptides
Material Category
MABSol® Biotin Labeled Proteins
Supplier
ACROBiosystems
Storage Tempreture
-20℃
Species
Human
Host
HEK293
Product Type
MABSol® Biotin Labeled Proteins
Format
Powder
Purity
90%
Conjugate
Biotin-labeled
Bioactivity
LRRC15 (Leucine-rich repeat-containing protein 15) is also known as LIB and hLib. LRRC15 is highly expressed in a variety of solid tumors. LRRC15 was expressed on stromal fibroblasts in many solid tumors (e.g., breast, head and neck, lung, pancreatic) as well as directly on a subset of cancer cells of mesenchymal origin (e.g., sarcoma, melanoma, glioblastoma). LRRC15 expression was induced by TGFβ on activated fibroblasts (αSMA+) and on mesenchymal stem cells. These collective findings suggested LRRC15 as a novel CAF and mesenchymal marker with utility as a therapeutic target for the treatment of cancers with LRRC15-positive stromal desmoplasia or cancers of mesenchymal origin. ABBV-085 is a monomethyl auristatin E (MMAE)-containing antibody–drug conjugate (ADC) directed against LRRC15, and it demonstrated robust preclinical efficacy against LRRC15 stromal-positive/cancer-negative, and LRRC15 cancer-positive models as a monotherapy, or in combination with standard-of-care therapies.
Molecule
LRRC15
Tag
C-Fc & C-Avi
Expression System
HEK293
Expregion
Tyr 22 - Gly 538
Endotoxin Level
1.0 EU per μg
Buffer
PBS, pH7.4
